The generic injectables market is increasingly addressing the unique needs of pediatric and geriatric patients, two demographics with distinct physiological requirements and unmet therapeutic gaps. These segments, often overlooked by branded drug developers, are becoming critical growth areas as healthcare systems prioritize equitable access across all age groups. Pediatric patients require...